NU IGERT Nanomedicine Program on YouTube!
Take a tour with three former IGERT trainees, Brian Plouffe, Tatyana Chernenko and Yogesh Patel, to hear about some of the outstanding research that is done in the IGERT Nanomedicine program at Northeastern.
IGERT Nanomedicine Science and Technology is a new integrated doctoral
education program in the emerging field of Nanomedicine, created with
support from the National Cancer Institute and the National Science
Foundation. The program aims to educate the next generation of scientists
and technologists with the requisite skill sets to address scientific
and engineering challenges, with the necessary business, ethical and
global perspectives that will be needed in the rapidly emerging area of
applying nanotechnology to human health.
The program began at Northeastern University in 2005 with an NSF IGERT grant funded through the National Cancer Institute. The success of the program has since then led to an NSF funded IGERT renewal grant for the period 2010-2015 with new partners, Tuskegee University, The University of Puerto Rico Mayaguez and collaborators at hospitals affiliated with Harvard Medical School.
The program combines the interdisciplinary expertise of world-renowned faculty members in 11 departments at 3 Universities, collaborating with researchers at teaching hospitals and industry. Students enrolled in a Ph.D. program in Biology, Chemistry, Physics, Chemical Engineering, Mechanical/Industrial Engineering, Electrical/Computer Engineering, or Pharmaceutical Sciences (Northeastern University), Materials Science and Engineering or Integrative Biosciences (Tuskegee University), Applied Chemistry or Chemical Engineering (UPRM) may apply to the IGERT interdisciplinary program. The IGERT fellow will graduate with a Ph.D. degree in their core subject with specialization in Nanomedicine Science and Technology.
Download the IGERT Nanomedicine e-book summarizing the achievements of the Northeastern University IGERT Nanomedicine program
NEWS & EVENTS
April 14, 2016
Lipidic Templates and Coatings for Designing Nanotheranostics
Geoff D. Bothun, PhD, Associate Professor, Dept. of Chemical Engineering, U. Rhode Island
April 13, 2016
Commercialization of hemostatic agents: Progress and Challenges
Terrence W. Norchi, MD, President and CEO of Arch Therapeutics
View all events
January 21, 2016
SFB Top 5 Biomaterials Trends in 2016 features IGERT trainee, Ben Geilich
June 23, 2015
Students Explore Nanomedicine Research on CaNCURE Co-ops
View all news
Young Scholars Program
The Young Scholars Program offers future scientists and engineers an opportunity for hands-on experience while still in high school.